BM8 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biomarin Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 47.15 EUR 2.81% Market Closed

Market Cap: €8.9B

B	Biomarin Pharmaceutical Inc SWB:BM8	US
R	RVRC Holding AB F:0GE	SE
I	Industria de Diseno Textil SA WSE:ITX	ES
E	East Japan Railway Co F:EJR	JP
C	Carlisle Companies Inc SWB:CLE	US
	Abacus Global Management Inc NYSE:ABX	US
L	L'Oreal SA XMUN:LOR	FR
	Ellaktor SA OTC:ELLKF	GR
	Ally Financial Inc NYSE:ALLY	US
	Amtech Systems Inc NASDAQ:ASYS	US
B	Bushveld Minerals Ltd OTC:BSHVF	ZA

Profitability Summary

Biomarin Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

79%

Gross Margin is Increasing

77% > 80%

Low Operating Margin

10%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

3% > 10%

Low Net Margin

Sustainable 3Y Average Net Margin

11%

Net Margin is Increasing

3% > 8%

Exceptional Free Cash Flow Margin

23%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.